Semaglutide is nicely tolerated without having risk of hypoglycaemia in monotherapy but suffers from gastrointestinal adverse outcomes. A big inhabitants afflicted with COVID-19 infection ended up diabetic; as a result use of semaglutide in diabetic issues in addition to CV patients might be very much supportive in retaining wellbeing care https://robertm777alv9.wikilima.com/user